DCP
ABBV icon

Distillate Capital Partners’s AbbVie ABBV Stock Holding History

Distillate Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9M Sell
154,783
-105,590
-41% -$22.7M 2.03% 4
2026
Q1 		$56.6M Buy
260,373
+40,685
+19% +$9.02M 2.98% 1
2025
Q4 		$50.2M Sell
219,688
-6,633
-3% -$1.51M 2.58% 1
2025
Q3 		$52.4M Sell
226,321
-2,875
-1% -$585K 2.72% 1
2025
Q2 		$42.5M Sell
229,196
-24,397
-10% -$4.53M 2.28% 4
2025
Q1 		$53.1M Sell
253,593
-61,009
-19% -$11.9M 2.72% 3
2024
Q4 		$55.9M Buy
314,602
+26,804
+9% +$4.93M 2.75% 2
2024
Q3 		$56.8M Sell
287,798
-3,716
-1% -$694K 2.85% 8
2024
Q2 		$50M Buy
291,514
+291,434
+364,293% +$48.3M 2.65% 3
2024
Q1 		$14.6K Hold
80
– – 2.45% 19
2023
Q4 		$12.4K Hold
80
– – 2.7% 25
2023
Q3 		$11.9K Buy
80
+10
+14% +$1.47K 3.01% 27
2023
Q2 		$9.43K Hold
70
– – 3.05% 25
2023
Q1 		$11.2K Sell
70
-1
-1% -$153 2.86% 23
2022
Q4 		$11.5K Sell
71
-106,346
-100% -$16.3M 1.06% 28
2022
Q3 		$15.4M Sell
106,417
-8,915
-8% -$1.28M 2.06% 4
2022
Q2 		$17.7M Sell
115,332
-9,417
-8% -$1.44M 2.52% 3
2022
Q1 		$20.2M Sell
124,749
-2,039
-2% -$296K 2.88% 1
2021
Q4 		$17.2M Buy
126,788
+43,903
+53% +$5.19M 2.88% 1
2021
Q3 		$8.94M Buy
82,885
+13,733
+20% +$1.57M 2.38% 2
2021
Q2 		$7.79M Buy
+69,152
New +$7.79M 2.17% 4

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Distillate Capital Partners's ABBV Position: Q2 2026 in Review

Distillate Capital Partners reduced its AbbVie (ABBV) stake by 41% in Q2 2026, selling an estimated $22.7M and leaving 154,783 shares worth $38.9M. The position accounts for 2.03% of the portfolio, ranked #4.

Distillate Capital Partners first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $56.8M in Q3 2024. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Distillate Capital Partners held 154,783 shares of AbbVie worth $38.9M as of Q2 2026.
  • Distillate Capital Partners sold 105,590 AbbVie shares in Q2 2026, an estimated $22.7M.
  • AbbVie made up 2.03% of Distillate Capital Partners's portfolio in Q2 2026, its #4 holding.
  • Distillate Capital Partners first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • Distillate Capital Partners's AbbVie position peaked at $56.8M in Q3 2024.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.